Mid-term Subclinical Myocardial Injury Detection in Patients Who Recovered from COVID-19 According to Pulmonary Lesion Severity
Overview
Authors
Affiliations
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) may cause damage to the cardiovascular system during the acute phase of the infection. However, recent studies reported mid- to long-term subtle cardiac injuries after recovering from acute coronavirus disease 2019 (COVID-19). This study aimed to determine the relationship between the severity of chest computed tomography (CT) lesions and the persistence of subtle myocardial injuries at mid-term follow-up of patients who recovered from COVID-19 infection.
Methods: All patients with COVID-19 were enrolled prospectively in this study. Sensitive troponin T (hsTnT) and chest CT scans were performed on all patients during the acute phase of COVID-19 infection. At the mid-term follow-up, conventional transthoracic echocardiograph and global longitudinal strain (GLS) of the left and right ventricles (LV and RV) were determined and compared between patients with chest CT scan lesions of < 50% (Group 1) and those with severe chest CT scan lesions of greater or equal to 50% (Group 2).
Results: The mean age was 55 ± 14 years. Both LV GLS and RV GLS values were significantly decreased in group 2 ( = 0.013 and = 0.011, respectively). LV GLS value of more than -18 was noted in 43% of all the patients, and an RV GLS value of more than -20 was observed in 48% of them. The group with severe chest CT scan lesions included more patients with reduced LV GLS and reduced RV GLS than the group with mild chest CT scan lesions [(G1:29 vs. G2:57%, = 0.002) and (G1:36 vs. G2:60 %, = 0.009), respectively].
Conclusion: Patients with severe chest CT scan lesions are more likely to develop subclinical myocardial damage. Transthoracic echocardiography (TTE) could be recommended in patients recovering from COVID-19 to detect subtle LV and RV lesions.
Dehghan M, Mirzohreh S, Kaviani R, Yousefi S, Pourmehran Y Front Cardiovasc Med. 2024; 11:1458389.
PMID: 39628552 PMC: 11611865. DOI: 10.3389/fcvm.2024.1458389.
Tomar D, Kapoor A, Hashim Z, Raut K, Katheria A, Khare H Indian Heart J. 2024; 76(5):309-314.
PMID: 39362598 PMC: 11584371. DOI: 10.1016/j.ihj.2024.09.003.